Creative Biolabs builds NHP antibody phage display libraries from appropriately sourced non-human primate immune material when a research program needs to retain an NHP variable-region repertoire.
Creative Biolabs builds NHP antibody phage display libraries from appropriately sourced non-human primate immune material when a research program needs to retain an NHP variable-region repertoire. Projects can be organized within custom phage display library construction and coordinated with antibody library construction. Existing PBMCs, approved lymphoid material, RNA, or cDNA may be considered, with scFv/Fab construction, QC, optional screening, and any later humanization or full-length reformatting defined as separate modules.
Service at a Glance
Service Component
Project Scope
Starting Materials
Appropriately sourced NHP PBMCs, approved lymphoid material, RNA, or cDNA with species, study, and provenance records.
Library Formats
scFv or Fab phage display libraries selected according to sample resources and the downstream research workflow.
Core Construction
NHP-aware VH/VL recovery, fragment assembly, display-vector cloning, phage rescue, amplification, and release preparation.
Target-appropriate panning and candidate confirmation; humanization and full-length reformatting remain separate downstream modules.
The service is designed around sample traceability and repertoire recovery. NHP species, subspecies or strain where relevant, study context, collection timing, tissue source, sample handling, and sequence resources can all affect amplification and interpretation. These details are captured at the start so that the constructed library has a clear biological source and QC context.
NHP Project Readiness and Repertoire Strategy
Readiness Factor
Design Question
Project Response
Species and provenance
Is the NHP source unambiguous and linked to a defined study/material record?
Carry species, donor/animal identifier scheme, study context, sample type, collection point, and handling history into the library record.
Repertoire information
Is there enough NHP germline or repertoire information to design VH/VL recovery without a generic primer assumption?
Choose primer families, pooling, and replicate amplification against the best available source-specific sequence information.
Multiple donors / time points
Should samples be pooled or retained as sublibraries?
Keep separate pools when donor-specific biology matters; combine deliberately when aggregate representation is the objective.
Downstream scope
Does the project also request panning, humanization, or IgG reformatting?
Define these as separate stages so construction QC remains distinct from sequence engineering and molecule confirmation.
Material and authorization note. Submitted NHP material should be appropriately authorized for the proposed research, with documentation sufficient to support its use. Authorization review is handled as a project-readiness requirement rather than repeated throughout the service page.
NHP Library Construction Workflow
01
Review material and source records.
Confirm species, study context, sample identifiers, immune history, collection timing, sample type, RNA/cDNA status, and applicable material-use documentation.
02
Design NHP VH/VL recovery.
Select amplification strategies against available NHP germline or repertoire information, with replicate reactions or deliberate pooling where useful to reduce avoidable family dropout.
03
Assemble scFv or Fab constructs.
Define pairing strategy, orientation, linker or constant-domain context, cloning junctions, and productive reading frame for the selected display route.
04
Create and amplify the physical library.
Clone into a compatible display system, record physical clone recovery separately from sequence diversity, generate phage, and manage propagation as a potential bottleneck.
05
Release after QC.
Assess insert integrity, productive sequences, repertoire composition, redundancy, and display competence before optional selection.
QC and Deliverables
NHP library QC asks whether the constructed pool is structurally intact, sequence-productive, sufficiently representative for the agreed purpose, and display-competent. Representative sequencing can evaluate architecture, frame, stop codons, variable-gene use, CDR characteristics, and redundancy. The Phage Display NGS Service can provide deeper profiling when broader repertoire composition or propagation-associated shifts need to be characterized.
Creative Biolabs can provide a construction deliverable that includes the library material, clone/titer data, insert and sequence sampling, repertoire observations, display-related QC, and a technical report. When several donors or time points are present, the report can preserve sublibrary provenance so downstream enrichment remains interpretable.
Humanization and Reformatting Boundaries
NHP library construction recovers and displays the selected NHP repertoire; sequence humanization changes the candidate after discovery and is therefore planned as a separate engineering step. Likewise, moving a selected scFv or Fab into a full-length antibody creates a new molecular context that requires renewed binding and, where relevant, biophysical or functional assessment.
When target selection is requested, a qualified NHP library can proceed to Immunized Library Screening. Purified-antigen, cell-surface, competitive, or subtractive selection can be matched to the target problem, followed by clone-level sequencing and an appropriate binding assay such as ELISA, flow cytometry, SPR, or BLI.
What to Send Us
For a focused feasibility review, send the following project information for the NHP library:
01
Species / strain: exact NHP species/subspecies or strain where relevant, plus compliant source/provenance information
02
Sample type: available cells, tissue, RNA, or cDNA
03
Immune history: immune or study history linked to the submitted material
04
Collection timing: sampling point relative to immunization or the study design
05
RNA / cDNA status: material condition, available quantity, and existing quality information
06
Desired format: scFv or Fab, plus any anticipated reformatting
07
Screening / QC requirement: target format, screening requirement, QC depth, and any planned humanization or reformatting
Creative Biolabs can use these inputs to define a research-use-only construction plan and, when requested, connect it to downstream screening and candidate confirmation.
Published Data
Fig.1 PCR amplification of scFv libraries.1
Long-read sequencing of a rhesus macaque scFv phage-display library illustrates how deeper sequence analysis can reveal repertoire features that are not apparent from limited clone sampling. The study re-analyzed an existing library before and after antigen selection using full-length scFv circular consensus reads and immunoglobulin gene/clonotype annotation. In the unpanned library, 5,238 IGHV sequences assigned to clonotypes represented 2,569 distinct heavy-chain clonotypes, whereas the antigen-selected pool contained far fewer distinct IGHV clonotypes despite thousands of assigned sequences. IGHV3 and IGHV4 usage was prominent, and selection substantially changed gene and CDR3 distributions. The analysis also emphasized an important limitation of combinatorial scFv libraries: recovered VH and VL domains do not necessarily preserve native heavy/light-chain pairing. These observations are relevant to NHP library construction and QC because they show the value of separating physical library size from sequence diversity, monitoring repertoire changes introduced by selection, and interpreting gene usage against the available macaque reference framework. They do not establish a universal repertoire profile or screening outcome for other NHP species, donors, targets, or library designs.
Tell Us About Your Project Details
Creative Biolabs can use these inputs to define a research-use-only construction plan and, when requested, connect it to downstream screening and candidate confirmation.
Can an NHP library be built from existing PBMC RNA?
Yes, when species identity, study provenance, storage history, integrity, and quantity are compatible with the planned amplification. Existing RNA can shorten the upstream workflow, but primer-coverage planning and sample documentation remain part of project design.
Is germline humanization part of NHP library construction?
No. Library construction is used to recover and display the selected NHP repertoire. Humanization is a later sequence-engineering activity applied to selected candidates and is followed by renewed molecular characterization.
How are scFv or Fab hits transferred to IgG?
Selected variable regions can be moved into full-length expression constructs when reformatting is included. The new IgG-format molecule is expressed and retested using assays suited to the target and intended research use.
Can samples from multiple NHP donors or species be pooled?
Pooling can be considered, but it should not erase source identity. Donor, species, study context, and collection timing should remain traceable, and sublibraries may be preferable when donor-specific or species-specific interpretation is important. A combined pool is most useful when aggregate representation is the primary objective.
What documentation is needed before an NHP library project starts?
The project should provide unambiguous NHP species information, study and sample provenance, immune or exposure history, collection timing, sample type, storage or nucleic-acid status, and documentation supporting the authorized research use of the submitted material. These records are part of technical readiness because they define how the recovered repertoire can be interpreted.
Reference
Han, Seung Yub, et al. "Coupling of Single Molecule, Long Read Sequencing with IMGT/HighV-QUEST Analysis Expedites Identification of SIV gp140-Specific Antibodies from scFv Phage Display Libraries." Frontiers in Immunology 9 (2018): 329. Distributed under Open Access license CC BY, without modification. https://doi.org/10.3389/fimmu.2018.00329.
×
Online Inquiry
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
